Anders D Hove's Net Worth
$498 Million
Who is Anders D Hove?
Anders D Hove has an estimated net worth of $498 Million. This is based on reported shares across multiple companies, which include ARCA biopharma, Inc., Anacor Pharmaceuticals, Inc., Trubion Pharmaceuticals, Inc, Inspire Medical Systems, Inc., NEUROCRINE BIOSCIENCES INC, IRONWOOD PHARMACEUTICALS INC, Avalanche Biotechnologies, Inc., Edge Therapeutics, Inc., ALIMERA SCIENCES INC, Chelsea Therapeutics International, Ltd., and WORLD HEART CORP.
SEC CIK
Anders D Hove's CIK is 0001365618
Past Insider Trading and Trends
2010 was Anders D Hove's most active year for acquiring shares with 14 total transactions. Anders D Hove's most active month to acquire stocks was the month of September. 2016 was Anders D Hove's most active year for disposing of shares, totalling 19 transactions. Anders D Hove's most active month to dispose stocks was the month of March. 2010 saw Anders D Hove paying a total of $22,366,788.50 for 9,755,155 shares, this is the most they've acquired in one year. In 2015 Anders D Hove cashed out on 6,463,520 shares for a total of $115,209,962.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARCA biopharma, Inc. (ABIO) Snapshot price: $1.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anacor Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -33.89K |
$99.25 | -$3,363,185.50 |
0
|
Jun 24
| |||
Form 4
| -100.00% | -353.88K |
$99.59 | -$35,241,706.30 |
0
|
Scheduled
|
May 16
| ||
Form 4
| +267.73% | 257.65K |
$31.05 | $7,999,939.35 | 353.88K |
Scheduled
|
Apr 14
| ||
Form 4
| -70.44% | -229.30K |
$71.10 | -$16,303,945.12 | 96.23K |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| -73.44% | -900.00K |
$111.25 | -$100,125,000.00 | 325.54K |
Dec 15
| |||
Form 4
| -54.14% | -40.00K |
$117.36 | -$4,694,400.00 | 33.89K |
Dec 11
| |||
Form 4
| -23.55% | -400.19K |
$103.60 | -$10,390,562.00 | 1.3M |
Nov 10
| |||
Form 4/A
| -37.67% | -1.03M |
—
|
—
| 1.7M |
Nov 3
| |||
Form 4
| -41.35% | -1.13M |
—
|
—
| 1.6M |
Nov 3
| |||
Form 4
|
∞
| 794 |
—
|
—
| 794 |
Jun 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
| -0.73% | -20.00K |
$25.00 | -$500,000.00 | 2.73M |
Scheduled
|
Sep 26
| ||
Form 4
| -21.23% | -740.00K |
$24.87 | -$18,403,800.00 | 2.75M |
Scheduled
|
Sep 18 - Sep 19
| ||
Form 4
| -2.52% | -90.00K |
$24.99 | -$2,248,950.00 | 3.49M |
Scheduled
|
Sep 12 - Sep 16
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| -4.03% | -150.00K |
$14.06 | -$2,109,000.00 | 3.58M |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -0.51% | -19.27K |
$6.30 | -$121,456.52 | 3.73M |
Sep 20
| |||
Form 4
| -0.93% | -35.00K |
$6.51 | -$227,804.50 | 3.74M |
Sep 14
| |||
Form 4
| -0.66% | -25.18K |
$6.59 | -$165,932.26 | 3.78M |
Sep 11 - Sep 13
| |||
Form 4
| -17.74% | -820.55K |
—
|
—
| 3.8M |
Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
∞
| 4.63M |
$5.00 |
—
| 4.63M |
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Trubion Pharmaceuticals, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.86M |
—
|
—
|
0
|
Oct 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
∞
| 1.86M |
$13.00 |
—
| 1.86M |
Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inspire Medical Systems, Inc. (INSP) Snapshot price: $205.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.5M |
$16.00 |
—
| 1.5M |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $136.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||